This article was originally published in The Tan Sheet
Executive SummaryAn exclusive global licensing deal between Nestle USA and Jamba Juice will yield a line of healthy, ready-drink beverages under the Jamba brand name, the firms report Dec. 4. Launching in the U.S. in the 2008 second quarter, the products will comprise two offerings: Smoothies, a "nourishing blend of natural ingredients like real fruit and a splash of low-fat milk, and Juices, a lighter, refreshing blend of fruit with a splash of nonfat milk." The line will contain Emeryville, Calif.-based Jamba's vitamin and mineral boosts. "This is a tremendous opportunity for Jamba to grow brand awareness and increase the accessibility of Jamba products beyond the four walls of our stores," Jamba CEO Paul Clayton says...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.